fda glp-1 warning letters september 2025 CDER Jump 50% in FY — What That Means for Industry FDA issued 25 warning letters
Description
According to Law.com , AGs in states like Ohio and Connecticut have already taken action against med spas and online clinics promoting unauthorized compounded versions of drugs like semaglutide and tirzepatidethe active ingredients in Ozempic, Wegovy, and Mounjaro
Read now 3Case Library Large Hiatus Hernia with GERD Successfully Treated by Laparoscopic Nissen Fundoplicatio Read now 4Liver Cancer Can Liver Cancer Be Detected in Blood Tests
GLP-1 medications are not for everyone

While GLP-1R agonists have demonstrated cardiovascular benefits in clinical trials, including reduced rates of major adverse cardiovascular events (MACE) in T2DM patients, their antithrombotic efficacy is generally considered less potent than that of traditional antithrombotic agents
& Garber, A
